IN190388B - - Google Patents

Info

Publication number
IN190388B
IN190388B IN2930DE1998A IN190388B IN 190388 B IN190388 B IN 190388B IN 2930DE1998 A IN2930DE1998 A IN 2930DE1998A IN 190388 B IN190388 B IN 190388B
Authority
IN
India
Prior art keywords
active compound
biologically active
vesicles
mlcvs
multilamellar
Prior art date
Application number
Other languages
English (en)
Inventor
Lawrence Boni
Michael Batenjany
Stella Gevantmakher
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Publication of IN190388B publication Critical patent/IN190388B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906Drug delivery
    • Y10S977/907Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN2930DE1998 1997-10-01 1998-01-01 IN190388B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01

Publications (1)

Publication Number Publication Date
IN190388B true IN190388B (fr) 2003-07-26

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DE1998 IN190388B (fr) 1997-10-01 1998-01-01

Country Status (9)

Country Link
US (1) US6544549B1 (fr)
EP (1) EP1019026B1 (fr)
JP (1) JP2001517693A (fr)
AT (1) ATE286717T1 (fr)
AU (1) AU745000B2 (fr)
CA (1) CA2305533C (fr)
DE (1) DE69828624T2 (fr)
IN (1) IN190388B (fr)
WO (1) WO1999016426A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1857112B1 (fr) * 2005-03-09 2013-05-15 Sunstar Inc. Composition anticancer comprenant des liposomes qui contiennent des phytosterols
WO2007021822A2 (fr) * 2005-08-09 2007-02-22 The Research Foundation Of State Of University Of New York At Buffalo Compositions et procedes de preparation d'il-12 microparticulaire liposomale
EP3219307B1 (fr) * 2005-12-30 2021-09-08 NuVessl Inc. Nanoparticules lipidiques
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
US9283184B2 (en) 2008-11-24 2016-03-15 Massachusetts Institute Of Technology Methods and compositions for localized agent delivery
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
CN102917690B (zh) 2010-03-19 2016-08-24 麻省理工学院 脂质囊泡组合物和使用方法
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
WO2014068085A1 (fr) * 2012-11-02 2014-05-08 Cytuvax Composition comprenant des macro-agrégats de cytokine
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
CA3191031A1 (fr) 2013-09-27 2015-04-02 Massachusetts Institute Of Technology Nanostructures proteiques biologiquement actives sans entraineur
AU2016256979B2 (en) 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles
WO2017027843A1 (fr) 2015-08-12 2017-02-16 Massachusetts Institute Of Technology Couplage de nanoparticules à la surface cellulaire
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
CA3074826A1 (fr) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Compositions proteiques therapeutiques et procedes de preparation et d'utilisation de celles-ci
US20200078427A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
US20200188301A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method for Enhancing Passenger Molecule Loading
US20230096704A1 (en) * 2020-02-05 2023-03-30 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer
US20240285791A1 (en) * 2020-09-04 2024-08-29 Daegu Gyeongbuk Institute Of Science And Technology Extracellular vesicle expressing cytokine and antibody, method for producing same, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
EP0918539B1 (fr) 1996-02-16 2005-10-19 Biomira Usa Inc. Vaccin contre des malignites affectant les lymphocytes b

Also Published As

Publication number Publication date
ATE286717T1 (de) 2005-01-15
WO1999016426A2 (fr) 1999-04-08
CA2305533C (fr) 2009-12-01
EP1019026B1 (fr) 2005-01-12
AU9680098A (en) 1999-04-23
CA2305533A1 (fr) 1999-04-08
EP1019026A2 (fr) 2000-07-19
DE69828624T2 (de) 2005-12-22
JP2001517693A (ja) 2001-10-09
DE69828624D1 (de) 2005-02-17
AU745000B2 (en) 2002-03-07
WO1999016426A3 (fr) 1999-06-17
US6544549B1 (en) 2003-04-08

Similar Documents

Publication Publication Date Title
IN190388B (fr)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
IL144756A0 (en) Method for controlling liposome size
AU8141891A (en) Unilamellar vesicles
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
ATE203898T1 (de) Verfahren zur herstellung einer liposomen- zubereitung
CA2108288A1 (fr) Formulation cyclorosporine liposomal et procede de preparation
CA2138925A1 (fr) Methode pour la production de lipoproteines reconstituees
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
ATE228822T1 (de) Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen
CA2192190A1 (fr) Composition lipidique a base de diacylglycerol, de phospholipide, de liquide polaire et de principe actif d'origine biologique
WO1998037997A3 (fr) Metal poreux et procede de preparation
WO2003000227A3 (fr) Procede de preparation de vesicules chargees d'un materiau biologique et differentes utilisations desdites vesicules
GR3017118T3 (en) Liposomal-polyene preliposomal powder and method for its preparation.
JP2001517693A5 (fr)
KR880001284A (ko) 단일 이중층 리포좀의 제조방법
CA2187748A1 (fr) Liposomes de fusion, leurs procedes de preparation et d'utilisation
MY131524A (en) Liposomal itraconazole formulations
CA2118529A1 (fr) Methode d'application sur un tissu de materiaux de decollement
ES2086802T3 (es) Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
HUT62457A (en) Process for producing aqueous liposomal suspensions comprising an active ingredient
CA2202103A1 (fr) Methode de preparation d'une vesicule fermee
CA2101325A1 (fr) Agents acellulaires et cellulaires de nucleation de la glace et procede pour leur production
WO1999049716A3 (fr) Procede de preparation de formulations liposomales de principes actifs
CA2402364A1 (fr) Procede de production de camptothecine